Attorney Gabriel Holschneider is the chief executive officer of the Rainmaker Group. An active environmental advocate, Mr. Holschneider is a supporter of Fondo Mexicano para la Conservacion de la Naturaleza (Mexican Fund for the Conservation of Nature), a major nonprofit organization based in Latin America. In addition, Gabriel Holschneider contributes to Boston Children’s Hospital.
Through the years, Boston Children’s Hospital has served as a trailblazer for numerous breakthroughs in pediatrics. The hospital is credited as the first in history to successfully treat hydrocephalus via shunting - a process that reroutes excess fluid from the brain into another body cavity.
Sixty years later, Boston Children’s hydrocephalus program continues to be an industry leader in treatment. New shunting technologies such as externally programmable shunts have been successfully tested by the hospital. Moreover, the hydrocephalus program has been instrumental in the refinement of minimally invasive surgical techniques, including the landmark ETV/CPC (Endoscopic Third Ventriculostomy with Choroid Plexus Coagulation) procedure.
